Overlap between pathology of Alzheimer disease and vascular dementia.

There is overwhelming evidence to suggest that the neuropathology of Alzheimer disease (AD) extends beyond amyloid plaques and neurofibrillary tangles. Review of various consortium data shows that more than 30% of AD cases exhibit cerebrovascular pathology. However, certain vascular lesions such as cerebral amyloid angiopathy, microvascular degeneration, and periventricular white matter lesions are evident in almost all cases of AD. Whether these vascular lesions are coincidental or causal in the pathogenetic processes of AD remains to be defined. Although systemic vascular influences such as hypertension, coronary artery disease, and other cardiovascular disturbances may be responsible for such pathology in AD, it is equally intriguing that about one third of patients diagnosed with vascular dementia (VaD) will have AD-type pathology at autopsy. Moreover, previous studies have revealed that deficits in cholinergic indices related to the basal forebrain neurones are apparent in multi-infarct dementia. In this short review, we evaluate cerebrovascular pathology of AD in light of peripheral vascular pathophysiology implicated in the etiopathogenesis of the dementia. We also consider pathological findings in relation to genetic influences such as apolipoprotein E that may shed light on the link between AD and VaD. In view of these commonalties, it is reasonable to consider the same treatment strategies for both AD and VaD.

[1]  L. S. Perlmutter,et al.  Vascular basement membrane components and the lesions of Alzheimer's disease: Light and electron microscopic analyses , 1994, Microscopy research and technique.

[2]  A. Scheibel,et al.  DENERVATION MICROANGIOPATHY IN SENILE DEMENTIA, ALZHEIMER TYPE , 1987, Alzheimer disease and associated disorders.

[3]  D. Premkumar,et al.  Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease. , 1996, Brain research. Molecular brain research.

[4]  K. Blennow,et al.  A population study on blood-brain barrier function in 85-year-olds , 1998, Neurology.

[5]  G. Perry,et al.  Degeneration of amyloid precursor protein containing smooth muscle cells in cerebral amyloid angiopathy , 1993 .

[6]  Peter Martin Stroke and Alzheimer's Disease , 2000, Journal of neurology, neurosurgery, and psychiatry.

[7]  A. Delacourte,et al.  Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? , 1991, Journal of neurology, neurosurgery, and psychiatry.

[8]  R. Kalaria,et al.  Increased collagen content of cerebral microvessels in Alzheimer's disease , 1995, Brain Research.

[9]  I. Skoog The relationship between blood pressure and dementia: a review. , 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  P A Wolf,et al.  Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. , 1994, JAMA.

[11]  M. Margaglione,et al.  Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian Case-Control Study. , 1998, Stroke.

[12]  L. Wahlund,et al.  White matter hyperintensities in dementia: does it matter? , 1994, Magnetic resonance imaging.

[13]  Serum Protein Leakage in Alzheimer's Disease Revisited , 1997, Annals of the New York Academy of Sciences.

[14]  A. Smith,et al.  Comparison of Pathological Diagnostic Criteria for Alzheimer Disease , 1998, Alzheimer disease and associated disorders.

[15]  J. Blass,et al.  Absence of Vascular Dementia in an Autopsy Series from a Dementia Clinic , 1998, Journal of the American Geriatrics Society.

[16]  Mark A. Smith,et al.  Cerebrovascular muscle atrophy is a feature of Alzheimer's disease , 1998, Brain Research.

[17]  G. Román,et al.  Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. , 1987, JAMA.

[18]  P. Yates,et al.  IMMUNOHISTOCHEMICAL STAINING OF SENILE PLAQUES , 1982, Neuropathology and applied neurobiology.

[19]  A. Wallin The Overlap between Alzheimer’s Disease and Vascular Dementia: The Role of White Matter Changes , 1998, Dementia and Geriatric Cognitive Disorders.

[20]  James A. Mortimer,et al.  Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply , 1997 .

[21]  S. Gauthier,et al.  Apolipoprotein E polymorphism and Alzheimer's disease , 1993, The Lancet.

[22]  L. Thal,et al.  Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. , 1995, Archives of neurology.

[23]  B. Lernfelt,et al.  15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.

[24]  Yu-Min Kuo,et al.  Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. , 1998, The American journal of pathology.

[25]  Irma-Leena Notkola,et al.  Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease , 1998, Neuroepidemiology.

[26]  D. Gurwitz,et al.  (3-amyloid vasoactivity in Alzheimer's disease , 1996, The Lancet.

[27]  I. Skoog,et al.  Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions. , 1997, Archives of neurology.

[28]  H. Soininen,et al.  Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. , 1995, Stroke.

[29]  D. Reboussin,et al.  Cerebral Microvascular Alterations in Aging, Leukoaraiosis, and Alzheimer's Disease a , 1997, Annals of the New York Academy of Sciences.

[30]  B. Tavolato,et al.  Alzheimer's disease and senile brains: an immunofluorescence study. , 1983, Rivista di patologia nervosa e mentale.

[31]  H. Chui,et al.  Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review , 1990, Brain Research Bulletin.

[32]  F. Sakai,et al.  Normal human aging and cerebral vasoconstrictive responses to hypocapnia , 1979, Journal of the Neurological Sciences.

[33]  S. Younkin,et al.  Serum Amyloid P in Alzheimer's Disease , 1991, Annals of the New York Academy of Sciences.

[34]  C. Gandolfo,et al.  The integrity of the blood—Brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid , 1985, Journal of the Neurological Sciences.